News Releases
Visit Bachem at CPhI Worldwide 2023
Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing.
CPhI creates connections and stimulates partnerships in the global pharmaceutical industry. That is why Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing.
Don't miss the aperitif at their booth 7M40 on Wednesday, 25 October 2023.
You can visit us at any time and make an appointment with our experts: https://www.bachem.com/contact/
Learn more here >>>>>
More News Releases by Bachem
More Content From Bachem
-
-
-
Learn how the polarity and viscosity profiles of binary solvents can be used to predict their utility for producing different peptides by SPPS.
-
Scientists seek to discover new production routes when manufacturing limits arise.
-
Bachem Develops a Cost-Effective, Large-Batch Process for Octreotide Acetate Synthesis
-
Bachem's experts share their analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions.
-
Direct, robust and easy-to-use techniques to fully characterize the nucleotide sequence of highly modified single-stranded RNAs by top down tandem MS.
-
The pros and cons of today’s technologies for SPPS, native chemical ligation, CEPS, KAHA and recombinant technologies.
-
Learn how to reach commercial oligonucleotides API production in metric ton range with unbeaten process mass intensity and much more.
-
The peptide drug market has experienced significant growth in recent years and is expected to continue its upward trend in the coming years.
-
Solid phase peptide synthesis (SPPS) is a technique for peptide synthesis.
-
An interview with Sergey Malashikhin of Bachem on what’s behind the manufacturing of complex APIs.
-
Continuous chromatography is a promising solution due to its high productivity, improved selectivity, and reduced costs.
-
This tour is an exclusive walkthrough of Bachem’s oligonucleotide facilities in the company’s Headquarters, Bubendorf, Basel, Switzerland.
-
It is currently used as an active pharmaceutical ingredient in prescription medicines for the treatment of type II diabetes and Obesity.
